Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study record content and navigation. This blocks access to the trial details and related information on the page.SummaryDifference19%

- Check37 days agoChange DetectedThe page shows a revision tag updated to v3.6.6, replacing the previous v3.6.5. This indicates a small version update with no apparent changes to the visible content or study information.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a small update to the study record on ClinicalTrials.gov without altering the study information.SummaryDifference0.1%

- Check72 days agoChange DetectedThe revision tag updated from v3.6.3 to v3.6.4, indicating a new build or update to the page's backend/content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page's revision version was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the documentation.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.